Citations

Showing 10 of 108135 citations.

Resident Family and Medical Leave During the First Year of the American Board of Anesthesiology’s Extended Leave Policy
Dainer, Rupa J., Macario, Alex, Sun, Huaping , Warner, David O.

Mayo Clinic

Academic Medicine | September 29, 2021 | Volume: 96 | Issue: 10 | Pages: 1373-1373

10.1097/acm.0000000000004252 | PMID 34587138 Get It

SERPINA3 in glioblastoma and Alzheimer’s disease
Norton, Emily S. , Mesquita, Sandro Dá , Guerrero‐Cazares, Hugo , Da Mesquita, Sandro, Guerrero-Cazares, Hugo , Da Mesquita, Sandro

Mayo Clinic

Aging | September 29, 2021 | Volume: 13 | Issue: 18 | Pages: 21812-21813

10.18632/aging.203603 | PMID 34587119 Get It

Building your team and talent
Chaney, Amanda

Mayo Clinic

Journal of the American Association of Nurse Practitioners | September 29, 2021 | Volume: 33 | Issue: 10 | Pages: 761-762

10.1097/jxx.0000000000000649 | PMID 35561227 Get It

Interactions of ubiquitin and CHMP5 with the V domain of HD-PTP reveals role for regulation of Vps4 ATPase
Pashkova, Natalya, Yu, Liping, Schnicker, Nicholas J., Tseng, Chun-Che, Gakhar, Lokesh, Katzmann, David J., Piper, Robert C., Piper, Robert C. , Pashkova, Natalya , Piper, Robert C , Yu, Liping, Schnicker, Nicholas , Tseng, Chun-Che, Gakhar, Lokesh, Katzmann, David J.

Mayo Clinic

Molecular Biology of the Cell | September 29, 2021 | Volume: 32 | Issue: 22 | Pages: No page available

10.1091/mbc.e21-04-0219 | PMID 34586919 Get It

Structural studies reveal that the V domain of HD-PTP has two tandem binding sites for binding ubiquitin. Like its yeast counterpart Bro1, HD-PTP binds the Vps4 MIT domain, stimulating its activity in a manner that is augmented by ubiquitin binding.
A New Phenotypic Classification System for Dyslipidemias Based on the Standard Lipid Panel
Sampson, Maureen , Wolska, Anna , Wilson, Sierra R. , Meeusen, Jeffrey W. , Fatica, Erica M. , Otvos, James D. , Wilson, Peter, Amar, Marcelo , Shamburek, Robert D., Karathanasis, Sotirios K. , Remaley, Alan T. , Ballout, Rami A. , Soffer, Daniel E. , Donato, Leslie J. , Brinton, Eliot A. , Rosenson, Robert S.

Mayo Clinic

No container title available | September 29, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-923991/v1 Get It

Abstract BACKGROUND Dyslipoproteinemias can be classified by their distinct lipoprotein patterns, which helps determine atherosclerotic cardiovascular disease (ASCVD) risk and directs lipid management but this has required advanced laboratory testing. OBJECTIVE To develop a new algorithm for classifying lipoprotein disorders that only relies on the standard lipid panel. METHODS Lipid thresholds for defining the different lipoprotein phenotypes were derived for Non-High-Density Lipoprotein-Cholesterol (NonHDL-C) and Triglycerides (TG) to be concordant when possible with the current US Multi-Society guidelines for blood cholesterol management. RESULTS The new classification method categorizes patients into all the classical Fredrickson-like phenotypes except for Type III dysbetalipoproteinemia. In addition, a new hypolipidemic phenotype (Type VI) due to genetic mutations in apoB-metabolism is described. The validity of the new algorithm was confirmed by lipid analysis by NMR (N = 11,365) and by concordance with classification by agarose gel electrophoresis/beta-quantification (N = 5504). Furthermore, based on the Atherosclerosis Risk in Communities (ARIC) cohort (N = 14742), the lipoprotein phenotypes differ in their association with ASCVD (TypeV > IIb > IVb > IIa > IVa > normolipidemic) and can be used prognostically as risk enhancer conditions in the management of patients. CONCLUSIONS We describe a clinically useful lipoprotein phenotyping system that is only dependent upon the standard lipid panel. It, therefore, can be easily implemented for increasing compliance with current guidelines and for improving the care of patients at risk for ASCVD.
Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
Everhart, Alexander , Harper, Katrina , Jeffery, Molly M. , Levin, Zachary , Morden, Nancy E., Sankar, Ashwini , Karaca‐Mandic, Pinar , Jeffery, Molly Moore

Mayo Clinic

JAMA Network Open | September 29, 2021 | Volume: 4 | Issue: 9 | Pages: e2127349

10.1001/jamanetworkopen.2021.27349 | PMID 34586370 Get It

IL-23 amplifies the epithelial-mesenchymal transition of mechanically conditioned alveolar epithelial cells in rheumatoid arthritis-associated interstitial lung disease through mTOR/S6 signaling
Zhang, Chujie , Wang, Shaohua , Lau, Jessica, Roden, Anja C. , Matteson, Eric L. , Tschumperlin, Daniel J. , Vassallo, Robert , Tschumperlin, Daniel J , Vassallo, Robert , Sun, Jie , Luo, Fengming

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | September 29, 2021 | Volume: 321 | Issue: 6 | Pages: L1006-L1022

10.1152/ajplung.00292.2021 | PMID 34585990 Get It

Epithelial-mesenchymal transition (EMT) creates an environment facilitating fibrosis following alveolar epithelial cell injury. IL-23 has important roles in chronic autoimmune conditions like rheumatoid arthritis (RA), but its role in the interstitial lung disease that affects patients with RA is unclear. This study aimed to determine the profibrogenic role of IL-23 on somatic alveolar type I (ATI) epithelial cells. Primary ATI cells were isolated from rats and cultured on plastic dishes for 1–3 wk. After prolonged culture (≥14 days) on rigid culture dishes, primary ATI cells gradually acquired a mesenchymal phenotype, identified by decreased expression of caveolin-1, and reorganization of F-actin cytoskeleton, indicating the initiation of EMT by matrix stiffness. To determine how IL-23 promotes EMT in vitro, transitioning ATI cells, cultured on a stiff substrate for ≥14 days were stimulated with IL-23. The EMT phenotype was significantly enhanced by IL-23, which upregulated α-smooth muscle actin (α-SMA), collagen I/III protein, and decreased caveolin-1. Furthermore, IL-23 significantly promoted cell invasion, as well as apoptotic resistance on transitioning ATI cells. Mechanistically, IL-23-induced EMT was mammalian target of rapamycin/ribosomal protein S6 (mTOR/S6) signaling dependent and reversible by rapamycin. Transcriptional sequencing analysis of human lung fibrosis biopsy tissue revealed key roles for IL-23 in rheumatoid arthritis-associated interstitial lung disease (RA-ILD). This result was further validated by significantly upregulated IL-23 expression at the mRNA level in RA-ILD lung sections. Notably, transitioning ATI epithelial cells were abundantly detected in RA-ILD tissue. Taken together, these data support a role for IL-23 in the pathogenesis of RA lung fibrosis by promoting EMT in alveolar epithelial cells through mTOR/S6 signaling.
APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia
Liu, Chia‐Chen , Murray, Melissa E. , Li, Xia , Zhao, Na , Wang, Na , Shue, Francis , Martens, Yuka A. , Li, Yonghe , Raulin, Ana‐Caroline , Rosenberg, Cassandra L. , Doss, Sydney V. , Wren, Melissa C. , Jia, Lin , Ren, Yingxue , Ikezu, Tadafumi C. , Lü, Wenyan, Trottier, Zachary A. , Chen, Yixing , Linares, Cynthia , Wang, Xue , Kurti, Aishe, Asmann, Yan W. , Vemuri, Prashanthi , Kantarci, Kejal , Lowe, Val J. , Jack, Clifford R. , Parisi, Joseph E., Ferman, Tanis J. , Graff‐Radford, Neill R. , Petersen, Ronald C. , Younkin, Steven G. , Fryer, John Denis , Frieden, Carl , Ross, Owen A. , Bu, Guojun , Shue, Francis , Atagi, Yuka , Raulin, Ana-Caroline , Doss, Sydney V , Zhao, Jing , Wren, Melissa C , Ikezu, Tadafumi C , Caulfield, Thomas R , Trottier, Zachary A , Wszolek, Z.K. , Smith, Glenn E. , Vemuri, Prashanthi , Jack, Clifford R , Ferman, Tanis J , Boeve, Brad , Petersen, Ronald C , Younkin, Steven , Frieden, Carl , Dickson, Dennis W , Ross, Owen A , Bu, Guojun , Liu, Chia-Chen , Kantarci, Kejal , Murray, Melissa E , Zhao, Na , Chen, Yixing , Heckman, Michael G. , Zhao, Jing , Fu, Yuan , Caulfield, Thomas R. , Knight, Joshua A. , Wszołek, Zbigniew K. , Knopman, David S. , Boeve, Bradley F. , Wang, Hu , Han, Xianlin , Dickson, Dennis W.

Mayo Clinic

Science Translational Medicine | September 29, 2021 | Volume: 13 | Issue: 613 | Pages: No page available

10.1126/scitranslmed.abc9375 | PMID 34586832 Get It

A rare APOE variant APOE3 -Jac reduces self-aggregation and promotes healthy brain aging.
Free Flap Coverage for Complex Primary and Revision Total Knee Arthroplasty
Athey, Alexander G., Carlsen, Brian T. , Perry, Kevin I. , Moran, Steven L. , Wyles, Cody C. , Houdek, Matthew T.

Mayo Clinic

Plastic & Reconstructive Surgery | September 29, 2021 | Volume: 148 | Issue: 5 | Pages: 804e-810e

10.1097/prs.0000000000008452 | PMID 34586098 Get It

Background: Free flap coverage in the setting of a total knee arthroplasty is rare. The purpose of the current study was to evaluate the outcome of patients who underwent a free flap to assist with soft-tissue coverage following a complex total knee arthroplasty. Methods: The authors used their institutional total joint registry to retrospectively review patients undergoing a free soft-tissue flap in the setting of complex primary and revision total knee arthroplasty. Among 29,069 primary and 6433 revision total knee arthroplasties from 1994 to 2017, eight (0.02 percent) required a free flap for wound coverage. This included three primary total knee arthroplasties (0.01 percent) for posttraumatic arthritis and five revision total knee arthroplasties (0.07 percent) in the setting of infection. Median follow-up was 4 years. Results: Free flaps included vertical rectus abdominis (n = 3), anterior lateral thigh (n = 2), latissimus (n = 2), and transverse rectus abdominis (n = 1). There were no total flap losses; however, one patient required additional skin grafting. Reoperation occurred in six patients, of which four were revisions of the total knee arthroplasty for infection (n = 2) and tibial component loosening (n = 2). One patient ultimately underwent transfemoral amputation for persistent infection. Following reconstruction, there was improvement in the median Knee Society Score (49 versus 82; p = 0.03) and total range of motion between preoperative and postoperative assessments (70 degrees versus 85 degrees; p = 0.14). Conclusion: Free flap coverage in the setting of total knee arthroplasty was associated with a high rate of reoperation; however, the limb was able to be preserved in the majority of patients, with a reasonable functional outcome. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.